Ariane Dunant

13.0k total citations · 4 hit papers
82 papers, 8.5k citations indexed

About

Ariane Dunant is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ariane Dunant has authored 82 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Ariane Dunant's work include Lung Cancer Treatments and Mutations (28 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Research Studies (14 papers). Ariane Dunant is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Breast Cancer Treatment Studies (16 papers) and Lung Cancer Research Studies (14 papers). Ariane Dunant collaborates with scholars based in France, Austria and Italy. Ariane Dunant's co-authors include Jean‐Pierre Pignon, Thierry Le Chevalier, Maja Mockenhaupt, Luigi Naldi, Sima Halevy, Alexis Sidoroff, Jan Nico Bouwes Bavinck, Robert Pirker, Cécile Viboud and Jean‐Claude Roujeau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Ariane Dunant

82 papers receiving 8.3k citations

Hit Papers

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by ... 2006 2026 2012 2019 2008 2006 2007 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
    2008 1.8k citations Jean‐Pierre Pignon, Ariane Dunant et al. profile →
  2. DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
    2006 1.3k citations Ken A. Olaussen, Ariane Dunant et al. New England Journal of Medicine profile →
  3. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study
    2007 686 citations Maja Mockenhaupt, Cécile Viboud et al. Journal of Investigative Dermatology profile →
  4. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
    2010 474 citations Cynthia Haddad, Maja Mockenhaupt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariane Dunant France 35 3.7k 3.1k 2.3k 1.7k 1.4k 82 8.5k
Daniel D. Karp United States 43 3.8k 1.0× 4.8k 1.6× 618 0.3× 688 0.4× 136 0.1× 217 9.4k
Bin S. Teh United States 48 4.0k 1.1× 2.0k 0.6× 183 0.1× 685 0.4× 485 0.4× 374 8.4k
Steven G. DuBois United States 47 2.7k 0.7× 2.0k 0.7× 195 0.1× 911 0.5× 614 0.4× 281 7.4k
Kenichi Sugihara Japan 72 6.8k 1.8× 10.9k 3.5× 496 0.2× 2.5k 1.5× 381 0.3× 508 17.6k
R. Jakesz Austria 58 2.2k 0.6× 7.2k 2.3× 199 0.1× 1.5k 0.9× 256 0.2× 337 12.2k
Nigel Bundred United Kingdom 47 1.2k 0.3× 4.7k 1.5× 275 0.1× 2.7k 1.6× 103 0.1× 174 8.9k
Giampietro Gasparini Italy 43 1.5k 0.4× 4.1k 1.3× 395 0.2× 790 0.5× 105 0.1× 170 9.8k
Daniel J. DeAngelo United States 60 482 0.1× 4.3k 1.4× 378 0.2× 1.5k 0.8× 1.1k 0.8× 444 16.3k
David Khayat France 38 2.6k 0.7× 5.3k 1.7× 195 0.1× 1.2k 0.7× 69 0.1× 108 8.4k
Hellmut Samonigg Austria 41 1.2k 0.3× 4.0k 1.3× 140 0.1× 642 0.4× 191 0.1× 118 6.6k

Countries citing papers authored by Ariane Dunant

Since Specialization
Citations

This map shows the geographic impact of Ariane Dunant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane Dunant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane Dunant more than expected).

Fields of papers citing papers by Ariane Dunant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane Dunant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane Dunant. The network helps show where Ariane Dunant may publish in the future.

Co-authorship network of co-authors of Ariane Dunant

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane Dunant. A scholar is included among the top collaborators of Ariane Dunant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane Dunant. Ariane Dunant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michels, Judith, Catherine Genestie, Ariane Dunant, et al.. (2020). Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry. Gynecologic Oncology. 160(1). 77–82. 1 indexed citations
2.
Dunant, Ariane, et al.. (2020). Cost-effectiveness of preoperative magnetic resonance imaging to optimize surgery in ductal carcinoma in situ of the breast. European Journal of Radiology. 129. 109058–109058. 1 indexed citations
3.
Arriagada, R., Marcos Santos, C. Bourgier, et al.. (2017). Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. European Journal of Cancer. 76. 45–51. 31 indexed citations
4.
Chargari, Cyrus, R. Mazeron, Ariane Dunant, et al.. (2016). Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy. Clinical & Experimental Metastasis. 33(8). 775–785. 6 indexed citations
5.
Rotolo, Federico, Ariane Dunant, Thierry Le Chevalier, Jean‐Pierre Pignon, & R. Arriagada. (2014). Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach. Annals of Oncology. 25(11). 2162–2166. 24 indexed citations
6.
Ma, Xiaoli, Vanessa Rousseau, Haiji Sun, et al.. (2014). Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer. Molecular Oncology. 8(3). 555–564. 35 indexed citations
7.
Dunant, Ariane, Philippe Vielh, Chafika Mazouni, et al.. (2014). Added value of Virtual Touch IQ shear wave elastography in the ultrasound assessment of breast lesions. European Journal of Radiology. 83(5). 773–777. 91 indexed citations
8.
Bonvalot, Sylvie, Nils Ternès, Marco Fiore, et al.. (2013). Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought. Annals of Surgical Oncology. 20(13). 4096–4102. 162 indexed citations
9.
Haddad, Cynthia, Alexis Sidoroff, Sylvia H. Kardaun, et al.. (2013). Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: Are Drug Dictionaries Correctly Informing Physicians Regarding the Risk?. Drug Safety. 36(8). 681–686. 13 indexed citations
10.
11.
Sekula, Peggy, Yvonne Liß, Batya B. Davidovici, et al.. (2011). Evaluation of SCORTEN on a Cohort of Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Included in the RegiSCAR Study. Journal of Burn Care & Research. 32(2). 237–245. 58 indexed citations
12.
Voortman, Johannes, Akiteru Goto, Jean Mendiboure, et al.. (2010). MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma. Cancer Research. 70(21). 8288–8298. 109 indexed citations
13.
14.
Pichenot, C., Ariane Dunant, Corinne Balleyguier, et al.. (2009). Surgical Clips Assist in the Visualization of the Lumpectomy Cavity in Three-Dimensional Conformal Accelerated Partial-Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1320–1324. 55 indexed citations
15.
Filipits, Martin, Vincent Haddad, Katharina Schmid, et al.. (2007). Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program. Clinical Cancer Research. 13(13). 3892–3898. 66 indexed citations
16.
Mockenhaupt, Maja, Cécile Viboud, Ariane Dunant, et al.. (2007). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study. Journal of Investigative Dermatology. 128(1). 35–44. 686 indexed citations breakdown →
17.
Brambilla, Élisabeth, Jean‐Charles Soria, Vincent Haddad, et al.. (2007). PD2-3-4: Prognostic and predictive value of apoptosis related factors Fas, FasL and survivin in non small cell lung carcinoma patients enrolled in the IALT Trial. Journal of Thoracic Oncology. 2(8). S444–S445. 5 indexed citations
18.
Halevy, Sima, Pierre‐Dominique Ghislain, Maja Mockenhaupt, et al.. (2007). Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Journal of the American Academy of Dermatology. 58(1). 25–32. 342 indexed citations
19.
Fizazi, Karim, Jan Oldenburg, Ariane Dunant, et al.. (2007). Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Annals of Oncology. 19(2). 259–264. 61 indexed citations
20.
Olaussen, Ken A., Ariane Dunant, Pierre Fouret, et al.. (2006). DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy. New England Journal of Medicine. 355(10). 983–991. 1320 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel D. Karp Breakdown of academic impact, for papers by Bin S. Teh Breakdown of academic impact, for papers by Steven G. DuBois Breakdown of academic impact, for papers by Kenichi Sugihara Breakdown of academic impact, for papers by R. Jakesz Breakdown of academic impact, for papers by Nigel Bundred Breakdown of academic impact, for papers by Giampietro Gasparini Breakdown of academic impact, for papers by Daniel J. DeAngelo Breakdown of academic impact, for papers by David Khayat Breakdown of academic impact, for papers by Hellmut Samonigg
Rankless by CCL
2026